This is a newsletter from NextBioForm, a center coordinated by RISE with the goal to deliver better formulations for biopharmaceuticals. From the long-term perspective, our goal is to create stable biopharmaceuticals that will improve the quality of life for patients.
Read past NextBioForm newsletters and subscribe here |
|
| Finally, we have been able to meet in person again in NextBioForm. The consortium meeting in October attracted more than 40 participants to Sigtuna for two intense days with presentations from our young scientist, new partners and plenty of time for interaction. |
| Read more |
|
|
| We welcome Nanexa to the NextBioForm community! Nanexa is a drug delivery company focused on the drug delivery platform PharmaShell® for long acting injectables. |
| Read the full article here |
|
| "I am enjoying being a PhD student in NextBioForm. It is fun to be part of a large project and to learn from what the others are doing and by being close to the industry. I have learned a lot from the presentations by the industry partners, the mentor program, the NextBioForm courses, but foremost from attending various meetings." |
| Read the full interview |
|
|
| The interest in therapeutic proteins is increasing. However, proteins are fragile and needs to be stabilised against degradation to maintain their function. In this study, the influence of the excipient glycerol on the chemical degradation of protein in liquid formulations was examined. The results showed that glycerol strongly lowered the chemical degradation of a model protein by changing the tertiary structure of the protein. The results presented will help to develop better methods for the formulation and preservation of proteins. |
| Read the full article here |
|
|
